Abstract
Yueqi Leng, Canhui Cao, Weisi Lian, Mingmei Lin, Zhonghong Zeng, Dan Mo, Shangqi Li, Yilei He, Heng Pan
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Organoids: Development and Applications in Disease Models, Drug Discovery, Precision Medicine, and Regenerative Medicine
10.1002/mco2.735 · 2024
Bioengineering Approaches for the Advanced Organoid Research
10.1002/adma.202007949 · 2021
Organoid Cultures for Cancer Modeling
10.1016/j.stem.2023.05.012 · 2023
Decellularized Extracellular Matrix for Remodeling Bioengineering Organoid's Microenvironment
10.1002/smll.202207752 · 2023
Organoid Vascularization: Strategies and Applications
2025
Translational Organoid Technology—the Convergence of Chemical, Mechanical, and Computational Biology
10.1016/j.tibtech.2022.03.003 · 2022
Organoid Technologies for the Study of Intestinal Microbiota‐Host Interactions
10.1016/j.molmed.2022.02.001 · 2022
Organoid‐Driven Nanomedicine Platform Development
10.1016/j.biomaterials.2025.123611 · 2026
Bioengineering Toolkits for Potentiating Organoid Therapeutics
10.1016/j.addr.2024.115238 · 2024
A Brief History of Organoids
10.1152/ajpcell.00120.2020 · 2020
Establishment in Culture of Pluripotential Cells From Mouse Embryos
10.1038/292154a0 · 1981
Embryonic Stem Cell Lines Derived From human Blastocysts
10.1126/science.282.5391.1145 · 1998
Induction of Pluripotent Stem Cells From Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors
10.1016/j.cell.2006.07.024 · 2006
Extracellular Matrix Invasion in Metastases and Angiogenesis: “Commentary on the Matrigel ”Chemoinvasion Assay
10.1158/0008-5472.can-16-1971 · 2016
Single Lgr5 Stem Cells Build Crypt‐Villus Structures in Vitro Without a Mesenchymal Niche
10.1038/nature07935 · 2009
Study Transportation of Drugs Within Newly Established Murine Colon Organoid Systems
10.1002/adbi.202300103 · 2023
Lgr5+ve Stem Cells Drive Self‐Renewal in the Stomach and Build Long‐Lived Gastric Units in Vitro
10.1016/j.stem.2009.11.013 · 2010
Mouse Embryonic Stem Cell Culture for Generation of Three‐dimensional Retinal and Cortical Tissues
10.1038/nprot.2011.429 · 2011
Long‐term Expansion of Epithelial Organoids From human Colon, Adenoma, Adenocarcinoma, and Barrett's Epithelium
10.1053/j.gastro.2011.07.050 · 2011
Vascularized and Functional Human Liver From an iPSC‐Derived Organ Bud Transplant
10.1038/nature12271 · 2013
Cerebral Organoids Model human Brain Development and Microcephaly
10.1038/nature12517 · 2013
Kidney Organoids From Human iPS Cells Contain Multiple Lineages and Model Human Nephrogenesis
10.1038/nature15695 · 2015
In Vitro Generation of Human Pluripotent Stem Cell Derived Lung Organoids
10.7554/elife.05098 · 2015
Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients
10.1016/j.cell.2015.03.053 · 2015
Applications of human Organoids in the Personalized Treatment for Digestive Diseases
10.1038/s41392-022-01194-6 · 2022
An in Vivo Model of Functional and Vascularized human Brain Organoids
10.1038/nbt.4127 · 2018
Human Organoids‐on‐chips for Biomedical Research and Applications
10.7150/thno.90492 · 2024
Organoids for Disease Modeling and Treatment: State‐of‐the‐art
10.1186/s40164-026-00743-x · 2026
Organoids in Cancer Research and Regenerative Medicine: Current Status, Challenges, and Future Prospects
10.1002/mco2.70575 · 2020
Advances in human Organoids‐on‐chips in Biomedical Research
10.1093/lifemedi/lnad007 · 2023
Modeling human Embryo Implantation in Vitro
10.1016/j.cell.2025.10.027 · 2026
Designer Matrices for Intestinal Stem Cell and Organoid Culture
10.1038/nature20168 · 2016
Organogenesis in a Dish: Modeling Development and Disease Using Organoid Technologies
10.1126/science.1247125 · 2014
Modeling Development and Disease With Organoids
10.1016/j.cell.2016.05.082 · 2016
Modeling Mouse and human Development Using Organoid Cultures
10.1242/dev.118570 · 2015
Bioengineering Methods for Vascularizing Organoids
10.1016/j.crmeth.2024.100779 · 2024
Flow‐enhanced Vascularization and Maturation of Kidney Organoids in Vitro
10.1038/s41592-019-0325-y · 2019
Matrigel: Basement Membrane Matrix With Biological Activity
10.1016/j.semcancer.2005.05.004 · 2005
CRISPR Engineering in Organoids for Gene Repair and Disease Modelling
10.1038/s44222-022-00013-5 · 2023
CRISPR/Cas9 Genome‐Editing System in Human Stem Cells: Current Status and Future Prospects
10.1016/j.omtn.2017.09.009 · 2017
Patient‐derived Organoids Model Treatment Response of Metastatic Gastrointestinal Cancers
10.1126/science.aao2774 · doi-reference
A Functional CFTR Assay Using Primary Cystic Fibrosis Intestinal Organoids
10.1038/nm.3201 · doi-reference
Organoid Transplantation Can Improve Reproductive Prognosis by Promoting Endometrial Repair in Mice
10.7150/ijbs.69410 · doi-reference
Cytoskeletal and Inter‐cellular Junction Remodelling in Endometrial Organoids Under Oxygen‐glucose Deprivation: A New Potential Pathological Mechanism for Thin Endometria
10.1093/humrep/deae137 · doi-reference
Endometrial Thickness Is Associated With Incidence of Small‐for‐gestational‐age Infants in Fresh in Vitro Fertilization‐intracytoplasmic Sperm Injection and Embryo Transfer Cycles
10.1016/j.fertnstert.2019.12.014 · doi-reference
Endometrial Thickness Is a Risk Factor for Singleton Low Birth Weight from Single Blastocyst Transfer: A Retrospective Cohort Study
10.3389/fendo.2021.730512 · doi-reference
Live Births After Asherman Syndrome Treatment
10.1016/j.fertnstert.2021.05.099 · doi-reference
Thin Endometrium Is Associated With the Risk of Hypertensive Disorders of Pregnancy in Fresh IVF/ICSI Embryo Transfer Cycles: A Retrospective Cohort Study of 9,266 Singleton Births
10.1186/s12958-021-00738-9 · doi-reference
The Impact of a Thin Endometrial Lining on Fresh and Frozen‐thaw IVF Outcomes: An Analysis of Over 40 000 Embryo Transfers
10.1093/humrep/dey281 · doi-reference
Endometrial Thickness After Ovarian Stimulation With Gonadotropin, Clomiphene, or Letrozole for Unexplained Infertility, and Association With Treatment Outcomes
10.1016/j.fertnstert.2020.07.030 · doi-reference
Etiology, Risk Factors, and Management of Asherman Syndrome
10.1097/aog.0000000000005309 · doi-reference
Decoding the Endometrial Niche of Asherman's Syndrome at Single‐cell Resolution
10.1038/s41467-023-41656-1 · doi-reference
Microenvironment‐Protected Exosome‐Hydrogel for Facilitating Endometrial Regeneration, Fertility Restoration, and Live Birth of Offspring
10.1002/smll.202007235 · doi-reference
Regenerative Therapies for Refractory Thin Endometrium in in Vitro Fertilization
10.3389/fcell.2025.1668960 · doi-reference
Deciphering the Endometrial Niche of human Thin Endometrium at Single‐cell Resolution
10.1073/pnas.2115912119 · doi-reference
New Advances in the Treatment of Thin Endometrium
10.3389/fendo.2024.1269382 · doi-reference
Endometrial Thickness: How Thin Is Too Thin?
10.1016/j.fertnstert.2022.05.033 · doi-reference
GPX4 deficiency‐induced Ferroptosis Drives Endometrial Epithelial Fibrosis in Polycystic Ovary Syndrome
10.1016/j.redox.2025.103615 · doi-reference
Polycystic Ovary Syndrome in 2025‐insights and Innovations
10.1016/j.fertnstert.2025.09.025 · doi-reference
Endometrial Organoids: A Rising Star for Research on Endometrial Development and Associated Diseases
10.1007/s43032-021-00471-z · doi-reference
Polycystic Ovary Syndrome: A Metabolic Disorder With Therapeutic Opportunities
10.1016/j.cmet.2025.08.002 · doi-reference
Polycystic Ovary Syndrome: A ”Risk‐enhancing“ Factor for Cardiovascular Disease
10.1016/j.fertnstert.2022.03.009 · doi-reference
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
10.1210/er.2011-1034 · doi-reference
Signaling Pathways and Targeted Therapeutic Strategies for Polycystic Ovary Syndrome
10.3389/fendo.2023.1191759 · doi-reference
Polycystic Ovary Syndrome: Etiology, Pathogenesis and Diagnosis
10.1038/nrendo.2010.217 · doi-reference
The Latest Reports and Treatment Methods on Polycystic Ovary Syndrome
10.1080/07853890.2024.2357737 · doi-reference
Criteria, Prevalence, and Phenotypes of Polycystic Ovary Syndrome
10.1016/j.fertnstert.2016.05.003 · doi-reference
Pathophysiology and Nutritional Approaches in Polycystic Ovary Syndrome (PCOS): A Comprehensive Review
10.1007/s13668-023-00479-8 · doi-reference
CLINICAL PRACTICE. Polycystic Ovary Syndrome
10.1056/nejmcp1514916 · doi-reference
Polycystic Ovary Syndrome as a Metabolic Disease
10.1038/s41574-024-01057-w · doi-reference
Corroborating Evidence for Platelet‐induced Epithelial‐mesenchymal Transition and Fibroblast‐to‐myofibroblast Transdifferentiation in the Development of Adenomyosis
10.1093/humrep/dew018 · doi-reference
Adenomyosis and Infertility: Is There a Causal Link?
10.1080/17446651.2019.1697675 · doi-reference
Establishment of Adenomyosis Organoids as a Preclinical Model to Study Infertility
10.3390/jpm12020219 · doi-reference
The Effects of Anti‐TGF‐β1 on Epithelial‐Mesenchymal Transition in the Pathogenesis of Adenomyosis
10.1007/s43032-020-00139-0 · doi-reference
Current Medical Therapy for Adenomyosis: From Bench to Bedside
10.1007/s40265-023-01957-7 · doi-reference
Adenomyosis Pathogenesis: Insights From next‐generation Sequencing
10.1093/humupd/dmab017 · doi-reference
Pre‐clinical Models to Study Abnormal Uterine Bleeding (AUB)
10.1016/j.ebiom.2022.104238 · doi-reference
Perturbations of the Endometrial Immune Microenvironment in Endometriosis and Adenomyosis: Their Impact on Reproduction and Pregnancy
10.1007/s00281-025-01040-1 · doi-reference
Untangling the Independent Effect of Endometriosis, Adenomyosis, and ART‐related Factors on Maternal, Placental, Fetal, and Neonatal Adverse Outcomes: Results From a Systematic Review and Meta‐analysis
10.1093/humupd/dmae024 · doi-reference
Global Prevalence of Adenomyosis and Endometriosis: A Systematic Review and Meta‐analysis
10.1186/s12958-025-01483-z · doi-reference